Articles
| Open Access |
https://doi.org/10.55640/
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): CAUSES, CLINICAL SYMPTOMS, DIAGNOSIS AND TREATMENT METHODS
Tosheva Marjona Abdusalomovna , Department of Clinical Sciences of the Asia International University. Bukhara, Uzbekistan.Abstract
Chronic obstructive pulmonary disease (COPD) is a common inflammatory lung disease characterized by persistent respiratory symptoms and airflow limitation. According to the World Health Organization (WHO), COPD is the third leading cause of mortality in the world. For now, COPD has been a worldwide public health challenge to be paid attention to urgently.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend pharmacologic therapy, primarily inhaled corticosteroids and bronchodilators, as the preferred treatment for patients with stable COPD. However, these therapies do not effectively halt disease progression. Due to the complexity of its pathophysiology, non-pharmacologic interventions (e.g., physical activity) can have significant effects in improving the quality of life and prognosis, with favorable socioeconomic benefits.
Keywords
lungs, sputum, pollution, disease, oxygen, smoking.
References
Halpin D, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36.
Yang IA, Brown JL, George J, Jenkins S, McDonald CF, et al. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Med J Aust. 2017;207(10):436–42.
World Health Organization. The top 10 causes of death [EB/OL]. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 20 Dec 2021.
Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–17.
Rodrigues SO, Cunha CMCD, Soares GMV, Silva PL, Silva AR, Gonçalves-de-Albuquerque CF. Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease. Pharmaceuticals. 2021;14(10):979.
Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126–31.
Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–8.
Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study. Thorax. 2006;61(9):772–8.
Shu CC, Lee JH, Tsai MK, Su TC, Wen CP. The ability of physical activity in reducing mortality risks and cardiovascular loading and in extending life expectancy in patients with COPD. Sci Rep. 2021;11(1):21674.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.